PLoS ONE (Jan 2023)

Dataset of single nucleotide polymorphisms of immune-associated genes in patients with SARS-CoV-2 infection.

  • Nikoletta Katsaouni,
  • Pablo Llavona,
  • Yascha Khodamoradi,
  • Ann-Kathrin Otto,
  • Stephanie Körber,
  • Christof Geisen,
  • Christian Seidl,
  • Maria J G T Vehreschild,
  • Sandra Ciesek,
  • Jörg Ackermann,
  • Ina Koch,
  • Marcel H Schulz,
  • Daniela S Krause

DOI
https://doi.org/10.1371/journal.pone.0287725
Journal volume & issue
Vol. 18, no. 11
p. e0287725

Abstract

Read online

The SARS-CoV-2 pandemic has affected nations globally leading to illness, death, and economic downturn. Why disease severity, ranging from no symptoms to the requirement for extracorporeal membrane oxygenation, varies between patients is still incompletely understood. Consequently, we aimed at understanding the impact of genetic factors on disease severity in infection with SARS-CoV-2. Here, we provide data on demographics, ABO blood group, human leukocyte antigen (HLA) type, as well as next-generation sequencing data of genes in the natural killer cell receptor family, the renin-angiotensin-aldosterone and kallikrein-kinin systems and others in 159 patients with SARS-CoV-2 infection, stratified into seven categories of disease severity. We provide single-nucleotide polymorphism (SNP) data on the patients and a protein structural analysis as a case study on a SNP in the SIGLEC7 gene, which was significantly associated with the clinical score. Our data represent a resource for correlation analyses involving genetic factors and disease severity and may help predict outcomes in infections with future SARS-CoV-2 variants and aid vaccine adaptation.